.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Moodys
Merck
Colorcon
Healthtrust
Baxter
Queensland Health
Federal Trade Commission
UBS
Covington

Generated: December 15, 2017

DrugPatentWatch Database Preview

Drug Master Files for: Merck

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
21III11/3/1947MERCK AND CO INCNITROGEN MUSTARDS
169III7/13/1955MERCK SHARP AND DOHME RESEARCH LABORATORIES DIV MERCK AND CO INCMANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES.
175III8/24/1955MERCK AND CO INCPROCESS $ CONTROL DATE CONCERNING MANUFACTURE OF 2-ACETYLAMINA ETC.
253III4/27/1957MERCK AND CO INCAQUEOUS SOLN RADIO-A VITAMIN B12
271III1/1/1940MERCK AND CO INCNEOMYCIN SULFATE
293III4/14/1958MERCK AND CO INCHYDROCORT. 21-PHOSPHATE & NEOMYCIN SO4--OPTHAL. SOL. 0.5% & INJECT
551III4/19/1963MERCK SHARP AND DOHME RESEARCH LABORATORIES DIV MERCK AND CO INCTHIABENDAZOLE
603III6/3/1963MERCK SHARP AND DOHME RESEARCH LABORATORIES DIV MERCK AND CO INCHADACIDIN SOD. DIHYDRATE (NSC 521778) & HADACIDIN POTASS. NSC 72962
641III7/19/1963MERCK SHARP AND DOHME RESEARCH LABORATORIES DIV MERCK AND CO INC1-METHYL-1-(B-CHLOROETHYL) ETHYLENIMONIUM PICRYSULFONATE
678III9/3/1963MERCK AND CO INCPRO-STREP CRUMBLES (VET)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
US Department of Justice
Fish and Richardson
AstraZeneca
Citi
Express Scripts
Chinese Patent Office
Cipla
Cantor Fitzgerald
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot